0001209191-20-049674.txt : 20200904
0001209191-20-049674.hdr.sgml : 20200904
20200904210215
ACCESSION NUMBER: 0001209191-20-049674
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200903
FILED AS OF DATE: 20200904
DATE AS OF CHANGE: 20200904
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: TULLMAN GLEN
CENTRAL INDEX KEY: 0001213349
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38983
FILM NUMBER: 201162798
MAIL ADDRESS:
STREET 1: C/O LIVONGO HEALTH, INC.
STREET 2: 150 WEST EVELYN AVENUE, SUITE 150
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94041
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Livongo Health, Inc.
CENTRAL INDEX KEY: 0001639225
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370]
IRS NUMBER: 263542036
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 150 W. EVELYN AVE.
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94041
BUSINESS PHONE: 1(866)435-5643
MAIL ADDRESS:
STREET 1: 150 W. EVELYN AVE.
CITY: MOUNTAIN VIEW
STATE: CA
ZIP: 94041
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-03
0
0001639225
Livongo Health, Inc.
LVGO
0001213349
TULLMAN GLEN
C/O LIVONGO HEALTH, INC.
150 WEST EVELYN AVENUE, SUITE 150
MOUNTAIN VIEW
CA
94041
1
1
0
0
Executive Chairman
Common Stock
2020-09-03
4
M
0
422000
0.74
A
1348199
D
Common Stock
2020-09-03
4
S
0
422000
124.50
D
926199
D
Common Stock
1289209
I
See footnote
Common Stock
1580122
I
See footnote
Common Stock
146324
I
See footnote
Common Stock
235134
I
See footnote
Common Stock
260358
I
See footnote
Employee Stock Option (right to buy)
0.74
2020-09-03
4
M
0
422000
0.00
D
2024-02-12
Common Stock
422000
297954
D
On August 5, 2020, the Issuer entered into an Agreement and Plan of Merger with Teladoc Health, Inc. ("Teladoc") and Tempranillo Merger Sub, Inc., a wholly-owned subsidiary of Teladoc ("Merger Sub"), pursuant to which Merger Sub will merge with and into the Issuer, with the Issuer surviving as a wholly-owned subsidiary of Teladoc (the "Merger"). Pursuant to the terms of the Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2019, as amended and restated (the "Trading Plan"), all sales pursuant to the Trading Plan were automatically suspended following the public announcement of the Merger without any action by the reporting person, and the Trading Plan was subsequently terminated. The number of shares sold and reported on this form is consistent with the number of shares that would have been sold by the reporting person pursuant to the Trading Plan had the Trading Plan not been suspended in connection with the Merger.
In addition, in connection with the Merger the reporting person entered into a voting agreement with Teladoc and certain other stockholders of the Issuer party thereto (the "Voting Agreement"), pursuant to which, subject to certain exceptions, the reporting person agreed to vote all shares of the Issuer's common stock held by the reporting person in favor of the approval of the Merger. The sales reported on this form are expressly permitted and contemplated by the Voting Agreement, which permits the reporting person to sell or transfer a number of shares of the Issuer's common stock equivalent to such number of shares that would have been sold had the Trading Plan remained in effect. Following the sales reported on this form, the reporting person continues to hold over 85% of the shares of the Issuer's common stock and vested stock options directly held immediately prior to such sales.
The shares are held of record by 7wire Ventures Fund, L.P., or 7wire LP. The reporting person serves as a Manager of 7wire Management, LLC, or 7wire Management, the Manager of 7wire LP. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
The shares are held of record by 7wire Ventures LLC-Series EosHealth. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC-Series EosHealth. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
The shares are held of record by 7wire Ventures LLC - Series Livongo C. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo C. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
The shares are held of record by 7wire Ventures LLC - Series Livongo D. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo D. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
The shares are held of record by 7wire Ventures LLC - Series Livongo E. The reporting person serves as a Manager of 7wire Management, the Manager of 7wire Ventures LLC - Series Livongo E. The reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16 or for any other purpose.
Shares subject to the option are fully vested and immediately exercisable.
/s/ Jonathan Dorfman, by power of attorney
2020-09-04